Welcome to our dedicated page for Gamco Invs news (Ticker: GAMI), a resource for investors and traders seeking the latest updates and insights on Gamco Invs stock.
GAMCO Investors, Inc. (GAMI), known as Gabelli, regularly issues news and updates related to its asset management activities and investment products. As an investment advisory firm established in 1977, Gabelli communicates developments across mutual funds, closed-end funds, exchange-traded funds (ETFs), and separate accounts that it manages through its subsidiary Gabelli Funds, LLC.
News about GAMI often highlights changes and milestones in its product lineup. Recent announcements include the launch of actively managed ETFs such as the Gabelli High Income ETF (GBHI), the Keeley Dividend ETF (KDVD), and the Gabelli Opportunities in Live and Sports ETF (GOLS). These releases describe the funds’ objectives, such as seeking current income, capital appreciation, or exposure to specific themes like high yield credit, dividend-paying small- and mid-cap companies, or the global sports and live entertainment economy.
Company updates also cover broader developments in Gabelli’s ETF platform, such as the move to fully transparent actively managed ETFs, and provide details on strategies like Growth Innovators (GGRW), Global Technology Leaders (GGTL), Financial Services Opportunities (GABF), Commercial Aerospace & Defense (GCAD), High Income (GBHI), Keeley Dividend (KDVD), and Love Our Planet and People (LOPP). In addition, GAMI issues periodic earnings and operating results, including information on assets under management, revenue trends, and share repurchase or dividend decisions.
Investors following GAMI news can also see announcements from funds managed by Gabelli Funds, LLC, including distribution declarations and policy updates for The Gabelli Dividend & Income Trust, The Gabelli Healthcare & WellnessRx Trust, and The Gabelli Convertible and Income Securities Fund Inc. Monitoring this news flow helps readers understand how GAMCO Investors, Inc. is evolving its product set and communicating with shareholders across its various investment vehicles.
GAMCO Investors (OTCQX: GAMI) reported third-quarter 2025 results for the period ended September 30, 2025.
Key metrics: Quarterly revenue $63.2 million (+10% vs Q3 2024), EPS $0.68 (vs $0.69 a year earlier), quarter-end AUM $35.0 billion (+9% vs Q3 2024), and $200.8 million in cash and investments with no debt. The company repurchased 237,000 shares in Q3 and reported 22.1 million shares outstanding at quarter end.
Corporate actions: the Board authorized a 25% increase to the quarterly dividend to $0.10 per share, an additional 500,000 share buyback authorization, and a $2.5 million charitable contribution. The chairman and co-CEO waived his management fee for December.
GAMCO Investors (OTCQX: GAMI) announced that senior portfolio managers will speak at the IMPACT® 2025 conference in Denver. Mario J. Gabelli (Chief Investment Officer – Value), Kevin V. Dreyer (Co‑Chief Investment Officer – Value), and John T. Belton, CFA (Portfolio Manager – Growth) will host a session for advisors on November 5, 2025 from 1:30 p.m. to 2:30 p.m.
The conference runs November 4–6, 2025 at the Colorado Convention Center. The speakers will assess the global economy, characteristics of well‑performing stocks, and key investment themes. As of September 30, 2025, GAMCO reported approximately $35.0 billion in assets under management. Investors are reminded to review each fund prospectus for risks, fees, and objectives.
Gabelli Funds (GAMI) will host its 49th Annual Automotive Symposium on November 3–4, 2025 at The Encore at Wynn in Las Vegas, Nevada. The two-day event features presentations from senior management across the automotive and trucking ecosystem, including OEM suppliers, retailers, aftermarket service providers and next-gen electrification and autonomous technology firms.
Topics include tariffs, vehicle affordability, car complexity, autonomous transition, aftermarket resilience, and one-on-one investor meetings. A presenting company list and registration link are provided for attendees.
GAMCO Investors (OTCQX: GAMI) sent a letter to Lennar Corporation on October 10, 2025 regarding Lennar’s proposed exchange offer tied to up to 33,298,764 Millrose Properties Class A shares. GAMCO discloses it owns approximately 1,719,782 Lennar Class B shares (5.5%) of 31,217,013 Class B shares outstanding.
GAMCO supports the exchange’s goal to retire equity at an attractive valuation relative to Private Market Value, but objects that Lennar excluded Class B shareholders. GAMCO notes Class B trades at $111.43 while Class A trades at $118.77 (a 7% discount) and urges inclusion of Class B shareholders or permitting conversion to Class A to participate.
Gabelli Asset Management (GAMI) and Columbia Business School will host the 7th Annual Healthcare Symposium on Friday, November 14, 2025 at Convene 237 Park, New York City. This half-day program gathers healthcare executives, clinicians, and investors to discuss four topic panels: multi-cancer screening, beneficiary consumerism, aging in place, and vaccine access and development.
Speakers include executives from Quest Diagnostics, Exact Sciences, Guardant Health, Merck, AbbVie and panel moderators from Gabelli and Columbia. Registration and contact details are provided for investor inquiries.
Gabelli Funds (NYSE:GAMI) will host its 49th Annual Automotive Symposium on November 3–4, 2025 at The Encore at Wynn in Las Vegas, Nevada.
The two-day event features presentations by senior management from automotive OEM suppliers, retailers, aftermarket service providers and next‑gen electrification and tech companies, plus one‑on‑one investor meetings. Topics include tariffs, vehicle affordability, car complexity, autonomous vehicles, and aftermarket resilience. A presenting companies roster and registration link are provided for attendees.
Gabelli Asset Management (NYSE:GAMI) and Columbia Business School will host the 7th Annual Healthcare Symposium on Friday, November 14, 2025 at Convene 237 Park, 237 Park Avenue, New York City. This half-day event convenes healthcare executives, physicians, and investors to discuss trends including multi-cancer screening, consumer-driven beneficiary strategies, aging in place, and vaccine access and development.
The agenda lists timed panels with moderators from Gabelli and Columbia and speakers from Quest Diagnostics, Exact Sciences, Guardant Health, HealthEquity, WEX, Aetna, Oscar Health, InnovAge, SCAN, Signify Health, DispatchHealth, Merck, AbbVie, and Columbia medical/public health faculty. Registration and contact details are provided for attendees.
GAMCO Investors (OTCQX: GAMI) has announced preliminary financial results for Q3 2025. The company expects to report diluted earnings of $0.66 to $0.72 per share, compared to $0.69 per share in Q3 2024. Assets under management (AUM) reached $35.0 billion as of September 30, 2025, up from $32.2 billion year-over-year.
Founded in 1977, GAMCO manages assets for 27 open-end funds, 13 U.S. closed-end funds, 5 actively managed ETFs, and approximately 1,900 institutional and private wealth management investors. The company offers diverse investment solutions across various asset classes, regions, and investment styles. Detailed financial results will be reviewed in early November.
GAMCO Investors (OTCQX: GAMI) has announced its participation in the upcoming Sidoti Small-Cap Conference, scheduled for September 17th, 2025, at 1:45 PM. The presentation will be accessible via webinar registration.
Founded in 1977, Gabelli is a prominent investment advisory firm managing assets across 27 open-end funds, 13 U.S. closed-end funds, 5 actively managed ETFs, and other investment vehicles. The company serves approximately 1,900 institutional and private wealth management investors, primarily in the United States. Gabelli offers diverse investment solutions spanning multiple asset classes, regions, market capitalizations, and investment styles, with its flagship Gabelli Value strategy launched in 1977.
Gabelli Funds (OTCQX: GAMI) has announced its 3rd Annual PFAS Symposium, scheduled for September 17, 2025, at The Harvard Club in New York City. The event will bring together industry leaders, experts, and policymakers to discuss PFAS (Per- and Polyfluoroalkyl Substances) and their environmental impact.
The symposium will feature presentations from various companies including 374Water Inc. (NASDAQ: SCWO), AECOM (NYSE: ACM), and Minerals Technologies (NYSE: MTX), among others. The agenda includes discussions on PFAS uses, replacements, and remediation efforts in water treatment. The event will run from 8:45 AM with opening remarks by Rosemarie Morbelli, CFA, and continue through the afternoon with company presentations and expert discussions.